Clinical Trial Update: Prognostic and Predictive Impact of uPA/PAI-1 [Phase 3]

View source ↗

Summary

Phase 3 clinical trial investigating the prognostic and predictive impact of uPA/PAI-1 in breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Universitätsklinikum Hamburg-Eppendorf | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED